- Home
- SCLX vs EXYN Comparison
SCLX vs EXYN Comparison
Compare SCLX & EXYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCLX | EXYN |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1M | 47.6M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SCLX | EXYN |
|---|---|---|
| Price | $5.57 | $2.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 54.6K | ★ 1.1M |
| Earning Date | 04-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,253,000.00 | N/A |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $1.50 |
| 52 Week High | $34.27 | $6.98 |
Technical Indicators
Market Signals| Indicator | SCLX | EXYN |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 40.79 |
| Support Level | $5.48 | $1.65 |
| Resistance Level | $7.77 | $3.18 |
| Average True Range (ATR) | 0.39 | 0.43 |
| MACD | -0.08 | 0.10 |
| Stochastic Oscillator | 11.55 | 41.02 |
Price Performance
Historical ComparisonAbout SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.